Maybe Logo Early Access

Tools / Inside Trading Tracker

Inside Trading Tracker

Track insider trading activity at publicly traded companies to understand how executives are trading their shares.

    Avenue Therapeutics Inc. (ATXI) Insider Trading Activity

    Healthcare • Biotechnology • 3 employees

    Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida. Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.

    Total Value

    -$182.64

    Total Shares

    -84

    Average Trade Value

    -$91.32

    Most Active Insider

    Kranzler Jay D

    Total Activity: $137

    Largest Single Transaction

    $137

    by Kranzler Jay D on Nov 5, 2024

    30-Day Activity

    0 Transactions

    Volume: 0 shares
    Value: $0

    Name
    Position
    Date
    Shares
    Value
    Holdings
    Type
    Director
    Dec 2, 2024 23 $46 97 (-23.7%) Sale
    Director
    Nov 5, 2024 61 $137 559 (-10.9%) Sale